Skip to main content
Log in

Photoinstability of Some Tyrphostin Drugs: Chemical Consequences of Crystallinity

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. The purpose of this work was to study the photostability of the antiproliferative tyrphostin drug compounds RG 13022(I) and RG 14620(II) as a part of preformulation program.

Methods. The compounds were exposed to cool white fluorescent light in solution as well as in the solid state and analyzed by HPLC. The degradation products were isolated chromatographically and their structures determined by spectroscopic methods. X-ray crystallographic analyses of the above compounds and their solid state degradation products were carried out to understand the mechanism of photodegradation.

Results. The compounds were found to undergo efficient photochemical transformations in solution as well as in the solid state. The degradation in the solution was due to the photoisomerization into their E-isomers (III and IV). The solid state photodegradation products were [2 + 2]-cycloaddition products (V and VI). The stereochemistry of the photocycloaddition products was indicative of the crystal packing of their monomeric precursors. The photocycloaddition product of RG 13022 possesses the head-to-tail linkage as expected from the head-to-tail packing of RG 13022 molecules in the crystal. The photocycloaddition product of RG 14620, however, was found to involve head-to-head linkage in agreement with the head-to-head crystal packing of RG 14620.

Conclusions. Drug compounds containing open chain olefmic double bonds could be sensitive to mild condition of light in the solid state if the distance between the two double bonds in the crystal approaches 4.2°A and they have suitable UV absorption characteristics. Attractive interactions between chlorine atoms have significant influence in controlling the crystal packing of chlorinated aromatic compounds.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. A. Levitzki. Tyrphostins-Potential antiproliferative agents and novel molecular tools, Biochem. Pharmacology. 40:5:913–918 (1990).

    Google Scholar 

  2. T. Hunter and J. A. Cooper. Protein Tyrosine kinases, Annual Rev. Biochem. 54:897–930 (1985).

    Google Scholar 

  3. G. D. Plowman, A. Ullrich and L. K. Shawver. Receptor tyrosine kinases as targets for drug intervention. DN & P, 7, 6 (1994).

    Google Scholar 

  4. A. Levitzki and A. Gazit. Tyrosine kinase inhibition: An approach for the development of many drugs, Science. in press: (1994).

  5. J. J. Elder, G. J. Fischer, P. B. Lindquist, G. L. Bennett, M. R. Pittelkow, R. Coffey, L. Ellingsworth, R. Derynck and J. J. Vourhees. Overexpression of transforming growth factor alpha in psoriatic epidermis, Science. 243:811–814 (1988).

    Google Scholar 

  6. R. M. Lyall, A. Zilberstein, A. Gazit, C. Gilson, A. Levitzki and J. Schlessinger. Tyrphostins inhibit epidermal growth factor (EGF)-receptor tyrosine kinase activity in living cells and EGF-stimulated cell proliferation, J. Biol. Chem. 264:14503–14509 (1989).

    Google Scholar 

  7. B. Margolis, S. G. Ree, S. Felder, M. Merric, R. Lyall, A. Levitzki, A. Ullrich, a. Zilberstein and J. Schlessinger. EGF induces tyrosine phosphorylation of phospholipase C-II: A potential mechanism of EGF receptor signalling, Cell. 57:1101–1107 (1989).

    Google Scholar 

  8. A. Gazit, P. Yaish, C. Gilon, and A. Levitzki. Tyrphostins I: Synthesis and biological activity of protein tyrosine kinase inhibitors, J. Med. Chem. 32:2344–2352 (1989).

    Google Scholar 

  9. R. Ross. The pathogenesis of atheroclerosis, New Eng. J. of Medicine. 314:488–500 (1986).

    Google Scholar 

  10. Molecular Structure Corp. (1965). TEXSAN, Structure Analysis package, ver. 2.0, 3200A Research Forest Drive, The Woodlands, TX 77381 (1987).

  11. C. J. Gilmore, MITHRIL. A Computer Program for Automatic Solution of Crystal Structures, University of Glasgow, Glasgow, Scotland, 1983.

    Google Scholar 

  12. J. Luo, H. L. Ammon and G. J. Gilliland. PLOTMD, An IOn-teractive Program to modify molecular plots on a graphics terminal. J. Appl. Cryst.:22:186 (1989).

    Google Scholar 

  13. C. K. Johnson. ORTEP II, Report ORNL-5138. Oakridge National Laboratory, Oak Ridge, TN, (1976).

    Google Scholar 

  14. G. M. J. Schmidt. Pure Appl. Chem. 27:647 (1971).

    Google Scholar 

  15. G. R. Desiraju. Organic Solid State Chemistry, Elsevier, Amsterdam, 1987.

    Google Scholar 

  16. B. S. Green and G. M. J. Schmidt. Israel Chemical Society annual meeting abstracts. 190 (1971).

  17. B. S. Green and G. M. J. Schmidt. Topochemically-controlled Solid-state Photodimerization to a Tricyclo [6.2.0.03,6] Decane derivative, TetrahedronLetters. 4249 (1970).

  18. J. A. R. P. Sarma and G. R. Desiraju. Crystal Engineering via Cl Non bonded interactions. The Novel 2:1 Complex, 6-Chloro3′4,-(methylenedioxy)cinnamic acid. Topochemical conversion into an unsymmetrical cyclobutane and kinetics of the reaction, J. Chem. Soc., Chem. Commu. 145 (1984).

  19. F. H. Quina and D. G. Whitten. Medium effects on photochemical reactions. Photochemistry of surfactant Alkyl-4-Stilbazole salts in solution, in the solid state, and in monolayer assemblies, J. Am. Chem. Soc. 97:1602 (1975).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kumar, N., Windisch, V. & Ammon, H.L. Photoinstability of Some Tyrphostin Drugs: Chemical Consequences of Crystallinity. Pharm Res 12, 1708–1715 (1995). https://doi.org/10.1023/A:1016213721861

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1016213721861

Navigation